OLIGOMED - Oligonucleotides for Medical Applications

OLIGOMED is at the forefront of medical research, dedicated to addressing critical healthcare needs through innovative oligonucleotide technology. With a focus on cancer, Huntington's Disease, and cardiovascular diseases, OLIGOMED is pioneering a novel platform for personalized medicine. The company's multidisciplinary approach integrates cutting-edge science to develop advanced therapeutic solutions.

OLIGOMED's commitment to advancing oligonucleotide therapies is evident in its collaborative, intersectoral research network. By uniting world-class academic and private sector expertise in ON chemistry, bio-analysis, and medical applications, OLIGOMED is developing a next-generation ON platform technology. This involves combining tailored synthetic ONs with smart delivery systems, optimizing ON therapies through rigorous testing.

OLIGOMED is dedicated to delivering highly skilled scientific staff and fostering innovation in personalized medicine. The project encompasses top-tier training in organic and chemoenzymatic synthesis, ON analysis, and biomedical/medicinal testing, along with essential transferable skills. For a customized and exclusive company showcase and product listing, we invite the manager of OLIGOMED to contact us and complete the company profile.